Cite
THU0627 Differences in DAS28-CRP and DAS28-ESR Influence Disease Activity Stratification in Rheumatoid Arthritis and Could Influence Use of Biologics, Treatment Efficacy Evaluations and Decisions Regarding Treat-To-Target: An Analysis Using The BSRBR-RA: Table 1
MLA
Philip D H Hamann, et al. “THU0627 Differences in DAS28-CRP and DAS28-ESR Influence Disease Activity Stratification in Rheumatoid Arthritis and Could Influence Use of Biologics, Treatment Efficacy Evaluations and Decisions Regarding Treat-To-Target: An Analysis Using The BSRBR-RA: Table 1.” Annals of the Rheumatic Diseases, vol. 75, June 2016, p. 420.2-420. EBSCOhost, https://doi.org/10.1136/annrheumdis-2016-eular.1731.
APA
Philip D H Hamann, John D Pauling, Neil McHugh, Kimme L. Hyrich, & Gavin Shaddick. (2016). THU0627 Differences in DAS28-CRP and DAS28-ESR Influence Disease Activity Stratification in Rheumatoid Arthritis and Could Influence Use of Biologics, Treatment Efficacy Evaluations and Decisions Regarding Treat-To-Target: An Analysis Using The BSRBR-RA: Table 1. Annals of the Rheumatic Diseases, 75, 420.2-420. https://doi.org/10.1136/annrheumdis-2016-eular.1731
Chicago
Philip D H Hamann, John D Pauling, Neil McHugh, Kimme L. Hyrich, and Gavin Shaddick. 2016. “THU0627 Differences in DAS28-CRP and DAS28-ESR Influence Disease Activity Stratification in Rheumatoid Arthritis and Could Influence Use of Biologics, Treatment Efficacy Evaluations and Decisions Regarding Treat-To-Target: An Analysis Using The BSRBR-RA: Table 1.” Annals of the Rheumatic Diseases 75 (June): 420.2-420. doi:10.1136/annrheumdis-2016-eular.1731.